Breakthrough Molecular Dynamics with a Next-Gen Supercomputer for Biomedical Research
Official title: Breakthrough Molecular Dynamics Research via an Anton 3 Supercomputer
Funded at Carnegie-Mellon University · NIH-11385207 · Data updated 2026-11-12
A US national program provides researchers with access to the Anton 3 supercomputer to simulate biomolecules faster and at larger scales, helping scientists study diseases at the molecular level.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Carnegie-Mellon University NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project start | August 1, 2024 |
| Project end | April 30, 2029 |
| Funding year | 2026 |
| Award (this year) | $250,000 |
| NIH project number | 3R24GM154042-03S1 |
| Project ID | NIH-11385207 on NIH RePORTER |
Who could benefit from this research
✓Could help
Researchers and teams studying human diseases that involve biomolecular interactions could use the improved simulations to inform translational work.
✕Less likely to help
Direct patient benefit may be limited to researchers; individual patients are not enrolled in this grant.
What this research studies
This grant gives biologists and clinicians access to a powerful supercomputer to run advanced molecular simulations that could reveal how disease-related biomolecules behave over long timescales. Researchers from the biomedical community can use Anton 3 to model complex molecular systems up to seven million atoms, enabling deeper insights into disease mechanics. The project emphasizes maximizing the value of the resource through broad, creative use and collaboration, rather than focusing on a single experiment. NIH support, alongside the university and DESRES collaboration, helps expand capabilities for studying disease-related processes at the molecular level.
Why it matters
Potential benefit: If successful, patients could benefit from faster discovery of disease mechanisms and the development of targeted therapies informed by detailed molecular dynamics.
How similar studies have gone: Previous generations of the Anton system enabled major advances in biomolecular modeling, and the upgrade to Anton 3 aims to extend these gains further.
Where this research is happening
-
Carnegie-Mellon University
Pittsburgh, United States Active
Researchers
- Principal investigator: Blood, Philip D. — Carnegie-Mellon University
- Study coordinator: Blood, Philip D.
Related research
Other NIH-funded projects on the same topics.
-
Digital biomarkers to guide personalized rehab after ACL injury
Aims to use wearable sensors and phone videos to predict early osteoarthritis risk after ACL surgery so rehabilitation can be tailored to each patient.
-
Understanding early lung scarring in 3-D tissue environments
A new NIH grant aims to map where and how early lung scarring starts in three-dimensional tissue, with the goal of guiding better treatments for people with fibrotic lung diseases.
-
Understanding how iron- and 2-oxoglutarate–dependent enzymes help make halogenated compounds
This NIH grant supports research to uncover how a family of iron enzymes adds chlorine or other halogen atoms to biological molecules, which could lead to new ways to make safer, more effective cancer-fighting drugs.
-
How the brain plans and sequences everyday actions
This project looks at how connected brain areas plan and carry out multi-step movements so findings can help people with movement problems like Parkinson's disease.
-
ALT Cancer Telomere SUMOylation: Targeting a Achilles’ heel in cancer cells
A bright, patient-friendly look at a research project aiming to disrupt a cancer-specific process at the ends of chromosomes to slow or stop tumor growth.
-
Role of the ventral visual pathway in everyday actions
This grant studies how brain regions that process what we see help people perform daily tasks like gripping a cup or using utensils, especially after brain injury.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.